Clinical Study on Combined Immune Effect of EV71 Inactivated Vaccine
Evaluating Immunogenicity and Safety Effect on Combined Immune Effect of EV71 Inactivated Vaccine and HepB、MPSV-A、MR、JE-L：A Multi-center Randomized Controlled Trial
Sponsor: Hunan Provincial Center for Disease Control and Prevention
A PHASE4 clinical study on Enterovirus 71 Inactivated Vaccine and HFMD, this trial is ongoing. The trial is conducted by Hunan Provincial Center for Disease Control and Prevention and has accumulated 7 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Oct 2021 — Nov 2022 [monthly]
Unknown Status PHASE4
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status PHASE4
▶ Show 2 earlier versions
-
May 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — May 2020 [monthly]
Recruiting PHASE4
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hunan Provincial Center for Disease Control and Prevention
- Shaanxi Provincial Center for Disease Control and Prevention
- Shandong Province Centers for Disease Control and Prevention
For direct contact, visit the study record on ClinicalTrials.gov .